arrow
D

Denise Oró

medimmune
H指数:14
被引数:1,459

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct lung functional, histological and cell senescence signatures in the single and repetitive bleomycin mouse models of idiopathic pulmonary fibrosis

特发性肺纤维化单次和重复博莱霉素小鼠模型中肺部功能、组织学和细胞衰老特征的差异

2025-09-230
OAAI
Characterization of six clinical drugs and dietary intervention in the nonobese CDAA-HFD mouse model of MASH and progressive fibrosis

非肥胖CDAA-HFD小鼠MASH和进展性纤维化模型的六种临床药物及饮食干预的表征

2025-01-010
PRE
Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767
2024-12-010
OAAI
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis

Semaglutide降低GAN饮食诱导的肥胖和活检证实的nash-hcc晚期纤维化小鼠模型的肿瘤负担

2023-12-278
OAAI
Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

semaglutide,lanifibranor和饮食干预在GAN饮食诱导的肥胖和活检证实的NASH小鼠模型中的保肝作用

2022-02-2437
OA
Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma
2020-10-1440
OAAI
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

走向标准饮食诱导和活检证实的非酒精性脂肪性肝炎小鼠模型: 饮食脂肪来源的影响

2019-09-0789
OAAI
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals

与健康正常体重个体相比,不同程度非酒精性脂肪肝患者的肝转录组特征

2019-04-01177
OAAI